Search Results
Case 1: Bevacizumab in Stage IV Ovarian Cancer
GOG-0218: which patients with ovarian cancer experience highest benefit from 1L bevacizumab?
Case 1: Considerations for Debulking Surgery
Case-Based Overview: Pretreated Recurrent Ovarian Cancer
Dr. Tew Evaluates Bevacizumab Treatment in Ovarian Cancer
Bevacizumab for the treatment of patients with ovarian cancer exhibiting poor chemosensitivity
Dr. Essel Discusses Long-Term Bevacizumab in Ovarian Cancer
Bevacizumab in Ovarian Cancer
Ovarian Cancer: Moving to a Personalized Treatment Approach
PARP + Maintenance Bevacizumab in Ovarian Cancer
Upfront Bevacizumab in Advanced Ovarian Cancer
When to Add Bevacizumab for Recurrent Ovarian Cancer
